I have posted Tom's and my answers to the Chapter 1 questions that we discussed yesterday in section. Apparently, Question #4 on "OncoType DX" mortality/recurrence predictions was mildly controversial.
I have posted Tom's and my answers to the Chapter 1 questions that we discussed yesterday in section. Apparently, Question #4 on "OncoType DX" mortality/recurrence predictions was mildly controversial.